Biotech Surge Continues With Coherus Filing For $86M IPO
California-based Coherus BioSciences Inc., a clinical-stage company developing drugs patterned after several blockbusters slated to come off patent, became the latest biotech to join the initial public offering frenzy when it...To view the full article, register now.
Already a subscriber? Click here to view full article